366 related articles for article (PubMed ID: 31102185)
1. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.
Leibrand CR; Paris JJ; Jones AM; Masuda QN; Halquist MS; Kim WK; Knapp PE; Kashuba ADM; Hauser KF; McRae M
J Neurovirol; 2019 Aug; 25(4):560-577. PubMed ID: 31102185
[TBL] [Abstract][Full Text] [Related]
2. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794
[TBL] [Abstract][Full Text] [Related]
3. Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia.
Patel SH; Ismaiel OA; Mylott WR; Yuan M; McClay JL; Paris JJ; Hauser KF; McRae M
Neurosci Lett; 2019 Nov; 712():134475. PubMed ID: 31491466
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice.
Leibrand CR; Paris JJ; Ghandour MS; Knapp PE; Kim WK; Hauser KF; McRae M
Neurosci Lett; 2017 Feb; 640():136-143. PubMed ID: 28057474
[TBL] [Abstract][Full Text] [Related]
5. Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner.
Leibrand CR; Paris JJ; Jones AM; Ohene-Nyako M; Rademeyer KM; Nass SR; Kim WK; Knapp PE; Hauser KF; McRae M
Neurosci Lett; 2022 Sep; 788():136852. PubMed ID: 36028004
[TBL] [Abstract][Full Text] [Related]
6. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.
Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP
J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003
[TBL] [Abstract][Full Text] [Related]
7. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice.
Bruce-Keller AJ; Turchan-Cholewo J; Smart EJ; Geurin T; Chauhan A; Reid R; Xu R; Nath A; Knapp PE; Hauser KF
Glia; 2008 Oct; 56(13):1414-27. PubMed ID: 18551626
[TBL] [Abstract][Full Text] [Related]
8. Tools for eradicating HIV in the brain: prodrug dimeric inhibitors of P-gp.
Chmielewski J; Hrycyna C
Ther Deliv; 2012 Jun; 3(6):689-92. PubMed ID: 22838065
[TBL] [Abstract][Full Text] [Related]
9. Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?
Cattaneo D; Minisci D; Cozzi V; Riva A; Meraviglia P; Clementi E; Galli M; Gervasoni C
Antivir Ther; 2017; 22(4):353-356. PubMed ID: 28008867
[TBL] [Abstract][Full Text] [Related]
10. The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model.
Ellis K; Marlin JW; Taylor TA; Fitting S; Hauser KF; Rice G; McRae M
J Pharm Pharmacol; 2015 Feb; 67(2):178-88. PubMed ID: 25557407
[TBL] [Abstract][Full Text] [Related]
11. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.
Hayashi K; Pu H; Andras IE; Eum SY; Yamauchi A; Hennig B; Toborek M
J Cereb Blood Flow Metab; 2006 Aug; 26(8):1052-65. PubMed ID: 16395283
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
[TBL] [Abstract][Full Text] [Related]
13. HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells.
Liao K; Niu F; Hu G; Guo ML; Sil S; Buch S
Tissue Barriers; 2020 Apr; 8(2):1748983. PubMed ID: 32299282
[TBL] [Abstract][Full Text] [Related]
14. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
[TBL] [Abstract][Full Text] [Related]
15. Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes.
Chen K; Phan T; Lin A; Sardo L; Mele AR; Nonnemacher MR; Klase Z
PLoS One; 2020; 15(3):e0230563. PubMed ID: 32210470
[TBL] [Abstract][Full Text] [Related]
16. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability.
Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Fernandez SF; Chawda R; Shanahan TC; Schwartz SA
J Clin Immunol; 2008 Sep; 28(5):528-41. PubMed ID: 18574677
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat and morphine interactions dynamically shift striatal monoamine levels and exploratory behaviors over time.
Lark ARS; Nass SR; Hahn YK; Gao B; Milne GL; Knapp PE; Hauser KF
J Neurochem; 2024 Mar; 168(3):185-204. PubMed ID: 38308495
[TBL] [Abstract][Full Text] [Related]
18. Permeability of the blood-brain barrier to HIV-1 Tat.
Banks WA; Robinson SM; Nath A
Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.
Sultana S; Li H; Puche A; Jones O; Bryant JL; Royal W
J Neurovirol; 2010 Feb; 16(1):33-40. PubMed ID: 20113193
[TBL] [Abstract][Full Text] [Related]
20. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
